Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by ledrogon Sep 20, 2019 5:54pm

172 Views

Post# 30150137

RE:RE:RE:RE:Fear

No worries, too bad the chart didn't post but you can draw the chart yourself over at stockcharts.com, just go to "Range" and in the drop down menu click on "select start/end" and then put in Sept 1 2018 for the start and Sept 21 2018 for the end, you'll see that in the 8 days before the results came out for Reduce-It AMRN traded down for the first five days, then started to rebound the last three before absolutely exploding.

We've got another 5 trading days left without results if the thumb comes out Sept 30th as we're expecting. Here's hoping the thumb is up....I like our chances.

Bullboard Posts

Odd Burger to add 40 locations in Florida